Cognitive Behavioral Group Therapy in Panic Disorder Patients: The Efficacy of CBGT versus Drug Treatment

References

• Agras S, Leitenberg H, Barlow DH: Social reinforce-ment in the modification of agoraphobia. Archives of General Psychiatry 1968, 19, 423–427.
   PubMed Web of Science ®Google Scholar
• Ballenger GC, Wheadon DE, Steiner M, et al. Double-blind, fixed-dose placebo-controlled study of paroxet-ine in the treatment of panic disorder. Am J Psychiatry 1998, 155(1):36–42.
   PubMed Web of Science ®Google Scholar
• Barlow DH: Anxiety and its Disorders: The nature and treatment of anxiety and panic. New York: Guilford Press, 1988.
   Google Scholar
• Barlow DH, Gorman JM, Shear MK, Woods SW: CBT, imipramine or combination for PD. JAMA 2000, 283: 2529–2536.
   PubMed Web of Science ®Google Scholar
• Barlow DH, Craske MG, Cerny JA, Klosko JS: Behavioral treatment of panic disorder. Behav Ther 1989, 20:261–282.
   Web of Science ®Google Scholar
• Barlow DH, Lechman CL: Advances in the psychosocial treatment of anxiety disorders. Archives of General Psychiatry 1996, 53:727–735.
   PubMed Web of Science ®Google Scholar
• Beck AT, Emergy G, Greenberg RL: Anxiety Disorders and Phobias: A Cognitive Perspective. New York: Basic Books, 1985.
   Google Scholar
• Beck AT, Sokol L, Clark DA, Berckick R, Wright, F: A crossover study of focused cognitive therapy for panic dis-order. American Journal of Psychiatry 1992, 149:778–783.
   PubMed Web of Science ®Google Scholar
• Bourne EJ: The Anxiety and Phobia Workbook. Oakland, CA: New Harbinger, 1995.
   Google Scholar
• Clark DM: A cognitive approach to panic. Behavior Research and Therapy 1986, 24:461–470.
   PubMed Web of Science ®Google Scholar
• Clark DM: Cognitive therapy for panic disorder. In Gath D and Goeting NM ed., Panic Disorder: Current Approaches. Duphar Medical Relations, 1990: 55–62.
   Google Scholar
• Clark DM et al. A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder. British Journal of Psychiatry 1994, 164: 759–769.
   PubMed Web of Science ®Google Scholar
• Clark DM et alet al.: Brief cognitive therapy for panic disorder: A randomized controlled trial. J Consult Clin Psychol 1999, 4:583–589.
   Web of Science ®Google Scholar
• Craske MG, Brown, TA: Behavioral treatment of panic: A two year follow-up. Behav Ther 1991, 22:289–304.
   Web of Science ®Google Scholar
• Dyckman JM, Rosenbaum RL, Hartmeyer RJ, Walter LJ: Effects of psychological intervention on panic attack patients in the Emergency Department. Psycho-somatics 1999, 40:422–427.
   Google Scholar
• Gelder MG: Combined pharmocotherapy and cognitive behavior therapy in the treatment of panic disorder. Journal of Clinical Psychopharmacology 1998, 18 (6 Suppl 2):25–55.
   Google Scholar
• Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959, 32:50–55.
   PubMed Web of Science ®Google Scholar
• Guy W: Early Clinical Drug Evaluation Unit Assessment Manual for Psychopharmacology, rev. ed. Washington, DC: Dept. of Health, Education and Welfare, 1976.
   Google Scholar
• Kessler RC, McGonagle KA, Zhao S et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994, 51:8–19.
   PubMed Web of Science ®Google Scholar
• Lecrubier, Y, Bakker A, Dunber G, et al. A comparison of paroxetine, clompiramine and placebo in the treat-ment of panic disorder. Acta Psychiatr Scand 1997, 95: 145–152.
   PubMed Web of Science ®Google Scholar
• Loerch B, Graf-Morgenstern M, Houtsinger M, et al.: Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia. British Journal of Psychiatry 1999, 174:205–212.
   PubMed Web of Science ®Google Scholar
• Michaelson D, Lydiard RB, Pollack MH et al: Outcome assessment and clinical improvement in panic disorder: Evidence from randomized controlled trial of fluoxitine and placebo. American Jounal of Psychiatry 1998, 155: 1570–1577.
   Google Scholar
• Nadiga DN, Hensley PL, Uhlenhuth, EH: Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder. Depression and Anxiety 2003, 17:58–64.
   PubMed Web of Science ®Google Scholar
• Oehrberg S, Christiansen PE, Behnke K et al Paroxet-ine in the treatment of panic disorder: A randomized, double-blind, placebo controlled study. British Journal of Psychiatry 1995, 167:374–379.
   PubMed Web of Science ®Google Scholar
• Otto MW et al.: Discontinuation of benzodiazepine treatment. American Journal of Psychiatry 1993, 150: 1485–1490.
   PubMed Web of Science ®Google Scholar
• Otto MW, Pollack MH, Penava SJ, Zucker BG: Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: A clinical case series. Behav Res Ther 1999, 37(8): 763–770.
   PubMed Web of Science ®Google Scholar
• Schmidt NB, Wollaway-Bichel K et al. Antidepressant discontinuation in the context of cognitive-behavioral treatment for panic disorder. Behav Res Ther 2002, 40(1):67–73.
   PubMed Web of Science ®Google Scholar
• Sokol L, Beck AT, Greenberg RL et al.: Cognitive therapy of panic disorder: A nonpharmacological alternative. J Nerv Men Dis 1989, 177:711–716.
   PubMedGoogle Scholar
• Spiegel DA, Bruce TJ, Gregg SF, Nuzzarello A: Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder? American Journal of Psychiatry 1994, 151:876–881.
   PubMed Web of Science ®Google Scholar
• Tekh MJ, Lucas JA, Schmidt NB et al. Group cognitive-behavioral treatment of panic disorder. Behav Res Ther 1993, 31, 279–287.
   Google Scholar
• Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, et al.: The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997, 54:305–309.
   PubMed Web of Science ®Google Scholar
• Zeally A, Aitken R: Visual analog scales. Proc Roy Soc Med 1969, 62:993–996.
   PubMedGoogle Scholar